Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Martie Miranda one of only 10 SATI accredited sign language interpreters in South Africa
2015-04-23

Martie Miranda
Photo: Stefan Lotter

The University of the Free State is privileged to have one of the top South African Sign Language (SASL) Interpreters as a staff member at the Unit for Students with Disabilities (USD).

Martie Miranda recently passed the accreditation exam of the South African Translators Institute (SATI), joining Dr Philemon Akach, previous HOD of the South African Sign Language Department of the UFS, in becoming one of only 10 SASL interpreters to be SATI accredited.

SATI is a professional association for language practice professionals in South Africa. Voluntary accreditation is offered at a professional level, ensuring a high standard of language practice. The system has become widely recognised, and is used as a recommendation or prerequisite for job applications by a number of institutions, including the South African government, particularly after the infamous ‘Jantjies incident’ with the funeral service of the late President Nelson Mandela.

Martie, a proud Child of Deaf Adults (CODA), has 18 years’ experience in SASL interpreting, lip speaking interpreting, and community interpreting as well as 15 years’ experience of conference and seminar interpreting. She boasts a Level 2 Advanced Interpreting qualification, and she has been mentoring Level 1 SASL interpreters for the past six years. Her extensive interpreting experience on a national and international level also includes Deafblind interpreting as well as Court and Legislature interpreting. She has interpreted three theatre productions, and has been coordinating the SASL services at the UFS since January 2009. She is responsible for the student management of all the hearing-impaired students at the USD.

Martie completed her BML degree (cum laude) at the UFS Business School in 2013, and received the award for top achiever in the programme during her final year. She will enrol for her MBA at the UFS Business School in July 2015.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept